You are here

Article Text

Article menu
Download PDFPDF
PostScript
Correspondence
Peribronchial tertiary lymphoid structures persist after rituximab therapy in patients with cystic fibrosis

https://doi.org/10.1136/jclinpath-2018-205160

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Handling editor Dhirendra Govender.

    • Contributors LR, CM, PRB designed the study. LR, CM, VG acquired the data. LZ, ES contributed to sample collection. LR and PRB wrote the manuscript. All authors reviewed the data and the final manuscript.

    • Funding This work was funded by Legs Poix-Chancellerie des Universités de Paris and Vaincre la Mucoviscidose, Paris, France.

    • Competing interests None declared.

    • Patient consent Not required.

    • Ethics approval The study was approved by the local ethics committee (CPP Ile de France II; #1072) for the use of samples of human origin.

    • Provenance and peer review Not commissioned; externally peer reviewed.